ArticleEndocrine2018
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study.
A Albani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it